Global Microbiome CDMO Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Microbiome CDMO market size was valued at US$ 1744 million in 2025 and is forecast to a readjusted size of US$ 3283 million by 2032 with a CAGR of 9.6% during review period.
Microbiome CDMO (Contract Development and Manufacturing Organization) is an organization that specializes in providing customized manufacturing and development services to biotechnology and pharmaceutical companies. They mainly focus on providing microbiome research with the entire process from samples to commercial products, including microbiome isolation, culture, identification, storage, extraction, preparation and related product development.
With the continuous deepening of microbiome research, more and more companies and research institutions have begun to realize the application potential of microbiome in medicine, agriculture, food and other fields, which has brought huge market demand to the microbiome CDMO industry.
This report is a detailed and comprehensive analysis for global Microbiome CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Global Microbiome CDMO market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Microbiome CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Microbiome CDMO market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chapter 2, to profile the top players of Microbiome CDMO, with revenue, gross margin, and global market share of Microbiome CDMO from 2021 to 2026.
Chapter 3, the Microbiome CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Microbiome CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microbiome CDMO.
Chapter 13, to describe Microbiome CDMO research findings and conclusion.
Microbiome CDMO (Contract Development and Manufacturing Organization) is an organization that specializes in providing customized manufacturing and development services to biotechnology and pharmaceutical companies. They mainly focus on providing microbiome research with the entire process from samples to commercial products, including microbiome isolation, culture, identification, storage, extraction, preparation and related product development.
With the continuous deepening of microbiome research, more and more companies and research institutions have begun to realize the application potential of microbiome in medicine, agriculture, food and other fields, which has brought huge market demand to the microbiome CDMO industry.
This report is a detailed and comprehensive analysis for global Microbiome CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microbiome CDMO market size and forecasts, in consumption value ($ Million), 2021-2032Global Microbiome CDMO market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Microbiome CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Microbiome CDMO market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Microbiome CDMO
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Microbiome CDMO market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Microbial CDMO
- Antibiotic CDMO
- Phage CDMO
- Bacteriocins CDMO
Market segment by Application
- Vaccine R&D
- Biopharmaceutical
- Cell Therapy
- Others
Market segment by players, this report covers
- Arranta Bio
- Wacker Chemie AG
- Bactera
- SGS Quay Pharma
- Biose
- EnteroBiotix
- Genome And Company
- Lallemand Health Solutions
- List Bio
- Rise BioServices
- Lonza
- MaaT Pharma
- NIZO
- Quay Pharmaceuticals
- Recipharm
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Microbiome CDMO product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Microbiome CDMO, with revenue, gross margin, and global market share of Microbiome CDMO from 2021 to 2026.
Chapter 3, the Microbiome CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Microbiome CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microbiome CDMO.
Chapter 13, to describe Microbiome CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microbiome CDMO by Type
1.3.1 Overview: Global Microbiome CDMO Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Microbiome CDMO Consumption Value Market Share by Type in 2025
1.3.3 Microbial CDMO
1.3.4 Antibiotic CDMO
1.3.5 Phage CDMO
1.3.6 Bacteriocins CDMO
1.4 Global Microbiome CDMO Market by Application
1.4.1 Overview: Global Microbiome CDMO Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Vaccine R&D
1.4.3 Biopharmaceutical
1.4.4 Cell Therapy
1.4.5 Others
1.5 Global Microbiome CDMO Market Size & Forecast
1.6 Global Microbiome CDMO Market Size and Forecast by Region
1.6.1 Global Microbiome CDMO Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Microbiome CDMO Market Size by Region, (2021-2032)
1.6.3 North America Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.4 Europe Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.6 South America Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Microbiome CDMO Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Arranta Bio
2.1.1 Arranta Bio Details
2.1.2 Arranta Bio Major Business
2.1.3 Arranta Bio Microbiome CDMO Product and Solutions
2.1.4 Arranta Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Arranta Bio Recent Developments and Future Plans
2.2 Wacker Chemie AG
2.2.1 Wacker Chemie AG Details
2.2.2 Wacker Chemie AG Major Business
2.2.3 Wacker Chemie AG Microbiome CDMO Product and Solutions
2.2.4 Wacker Chemie AG Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Wacker Chemie AG Recent Developments and Future Plans
2.3 Bactera
2.3.1 Bactera Details
2.3.2 Bactera Major Business
2.3.3 Bactera Microbiome CDMO Product and Solutions
2.3.4 Bactera Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bactera Recent Developments and Future Plans
2.4 SGS Quay Pharma
2.4.1 SGS Quay Pharma Details
2.4.2 SGS Quay Pharma Major Business
2.4.3 SGS Quay Pharma Microbiome CDMO Product and Solutions
2.4.4 SGS Quay Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 SGS Quay Pharma Recent Developments and Future Plans
2.5 Biose
2.5.1 Biose Details
2.5.2 Biose Major Business
2.5.3 Biose Microbiome CDMO Product and Solutions
2.5.4 Biose Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Biose Recent Developments and Future Plans
2.6 EnteroBiotix
2.6.1 EnteroBiotix Details
2.6.2 EnteroBiotix Major Business
2.6.3 EnteroBiotix Microbiome CDMO Product and Solutions
2.6.4 EnteroBiotix Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 EnteroBiotix Recent Developments and Future Plans
2.7 Genome And Company
2.7.1 Genome And Company Details
2.7.2 Genome And Company Major Business
2.7.3 Genome And Company Microbiome CDMO Product and Solutions
2.7.4 Genome And Company Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Genome And Company Recent Developments and Future Plans
2.8 Lallemand Health Solutions
2.8.1 Lallemand Health Solutions Details
2.8.2 Lallemand Health Solutions Major Business
2.8.3 Lallemand Health Solutions Microbiome CDMO Product and Solutions
2.8.4 Lallemand Health Solutions Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Lallemand Health Solutions Recent Developments and Future Plans
2.9 List Bio
2.9.1 List Bio Details
2.9.2 List Bio Major Business
2.9.3 List Bio Microbiome CDMO Product and Solutions
2.9.4 List Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 List Bio Recent Developments and Future Plans
2.10 Rise BioServices
2.10.1 Rise BioServices Details
2.10.2 Rise BioServices Major Business
2.10.3 Rise BioServices Microbiome CDMO Product and Solutions
2.10.4 Rise BioServices Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Rise BioServices Recent Developments and Future Plans
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business
2.11.3 Lonza Microbiome CDMO Product and Solutions
2.11.4 Lonza Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Lonza Recent Developments and Future Plans
2.12 MaaT Pharma
2.12.1 MaaT Pharma Details
2.12.2 MaaT Pharma Major Business
2.12.3 MaaT Pharma Microbiome CDMO Product and Solutions
2.12.4 MaaT Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 MaaT Pharma Recent Developments and Future Plans
2.13 NIZO
2.13.1 NIZO Details
2.13.2 NIZO Major Business
2.13.3 NIZO Microbiome CDMO Product and Solutions
2.13.4 NIZO Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 NIZO Recent Developments and Future Plans
2.14 Quay Pharmaceuticals
2.14.1 Quay Pharmaceuticals Details
2.14.2 Quay Pharmaceuticals Major Business
2.14.3 Quay Pharmaceuticals Microbiome CDMO Product and Solutions
2.14.4 Quay Pharmaceuticals Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Quay Pharmaceuticals Recent Developments and Future Plans
2.15 Recipharm
2.15.1 Recipharm Details
2.15.2 Recipharm Major Business
2.15.3 Recipharm Microbiome CDMO Product and Solutions
2.15.4 Recipharm Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Recipharm Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Microbiome CDMO Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Microbiome CDMO by Company Revenue
3.2.2 Top 3 Microbiome CDMO Players Market Share in 2025
3.2.3 Top 6 Microbiome CDMO Players Market Share in 2025
3.3 Microbiome CDMO Market: Overall Company Footprint Analysis
3.3.1 Microbiome CDMO Market: Region Footprint
3.3.2 Microbiome CDMO Market: Company Product Type Footprint
3.3.3 Microbiome CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Microbiome CDMO Consumption Value and Market Share by Type (2021-2026)
4.2 Global Microbiome CDMO Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Microbiome CDMO Consumption Value Market Share by Application (2021-2026)
5.2 Global Microbiome CDMO Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Microbiome CDMO Consumption Value by Type (2021-2032)
6.2 North America Microbiome CDMO Market Size by Application (2021-2032)
6.3 North America Microbiome CDMO Market Size by Country
6.3.1 North America Microbiome CDMO Consumption Value by Country (2021-2032)
6.3.2 United States Microbiome CDMO Market Size and Forecast (2021-2032)
6.3.3 Canada Microbiome CDMO Market Size and Forecast (2021-2032)
6.3.4 Mexico Microbiome CDMO Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Microbiome CDMO Consumption Value by Type (2021-2032)
7.2 Europe Microbiome CDMO Consumption Value by Application (2021-2032)
7.3 Europe Microbiome CDMO Market Size by Country
7.3.1 Europe Microbiome CDMO Consumption Value by Country (2021-2032)
7.3.2 Germany Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.3 France Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.5 Russia Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.6 Italy Microbiome CDMO Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Microbiome CDMO Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Microbiome CDMO Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Microbiome CDMO Market Size by Region
8.3.1 Asia-Pacific Microbiome CDMO Consumption Value by Region (2021-2032)
8.3.2 China Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.3 Japan Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.4 South Korea Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.5 India Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.7 Australia Microbiome CDMO Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Microbiome CDMO Consumption Value by Type (2021-2032)
9.2 South America Microbiome CDMO Consumption Value by Application (2021-2032)
9.3 South America Microbiome CDMO Market Size by Country
9.3.1 South America Microbiome CDMO Consumption Value by Country (2021-2032)
9.3.2 Brazil Microbiome CDMO Market Size and Forecast (2021-2032)
9.3.3 Argentina Microbiome CDMO Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Microbiome CDMO Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Microbiome CDMO Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Microbiome CDMO Market Size by Country
10.3.1 Middle East & Africa Microbiome CDMO Consumption Value by Country (2021-2032)
10.3.2 Turkey Microbiome CDMO Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Microbiome CDMO Market Size and Forecast (2021-2032)
10.3.4 UAE Microbiome CDMO Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Microbiome CDMO Market Drivers
11.2 Microbiome CDMO Market Restraints
11.3 Microbiome CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Microbiome CDMO Industry Chain
12.2 Microbiome CDMO Upstream Analysis
12.3 Microbiome CDMO Midstream Analysis
12.4 Microbiome CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Microbiome CDMO by Type
1.3.1 Overview: Global Microbiome CDMO Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Microbiome CDMO Consumption Value Market Share by Type in 2025
1.3.3 Microbial CDMO
1.3.4 Antibiotic CDMO
1.3.5 Phage CDMO
1.3.6 Bacteriocins CDMO
1.4 Global Microbiome CDMO Market by Application
1.4.1 Overview: Global Microbiome CDMO Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Vaccine R&D
1.4.3 Biopharmaceutical
1.4.4 Cell Therapy
1.4.5 Others
1.5 Global Microbiome CDMO Market Size & Forecast
1.6 Global Microbiome CDMO Market Size and Forecast by Region
1.6.1 Global Microbiome CDMO Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Microbiome CDMO Market Size by Region, (2021-2032)
1.6.3 North America Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.4 Europe Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.6 South America Microbiome CDMO Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Microbiome CDMO Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Arranta Bio
2.1.1 Arranta Bio Details
2.1.2 Arranta Bio Major Business
2.1.3 Arranta Bio Microbiome CDMO Product and Solutions
2.1.4 Arranta Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Arranta Bio Recent Developments and Future Plans
2.2 Wacker Chemie AG
2.2.1 Wacker Chemie AG Details
2.2.2 Wacker Chemie AG Major Business
2.2.3 Wacker Chemie AG Microbiome CDMO Product and Solutions
2.2.4 Wacker Chemie AG Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Wacker Chemie AG Recent Developments and Future Plans
2.3 Bactera
2.3.1 Bactera Details
2.3.2 Bactera Major Business
2.3.3 Bactera Microbiome CDMO Product and Solutions
2.3.4 Bactera Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bactera Recent Developments and Future Plans
2.4 SGS Quay Pharma
2.4.1 SGS Quay Pharma Details
2.4.2 SGS Quay Pharma Major Business
2.4.3 SGS Quay Pharma Microbiome CDMO Product and Solutions
2.4.4 SGS Quay Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 SGS Quay Pharma Recent Developments and Future Plans
2.5 Biose
2.5.1 Biose Details
2.5.2 Biose Major Business
2.5.3 Biose Microbiome CDMO Product and Solutions
2.5.4 Biose Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Biose Recent Developments and Future Plans
2.6 EnteroBiotix
2.6.1 EnteroBiotix Details
2.6.2 EnteroBiotix Major Business
2.6.3 EnteroBiotix Microbiome CDMO Product and Solutions
2.6.4 EnteroBiotix Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 EnteroBiotix Recent Developments and Future Plans
2.7 Genome And Company
2.7.1 Genome And Company Details
2.7.2 Genome And Company Major Business
2.7.3 Genome And Company Microbiome CDMO Product and Solutions
2.7.4 Genome And Company Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Genome And Company Recent Developments and Future Plans
2.8 Lallemand Health Solutions
2.8.1 Lallemand Health Solutions Details
2.8.2 Lallemand Health Solutions Major Business
2.8.3 Lallemand Health Solutions Microbiome CDMO Product and Solutions
2.8.4 Lallemand Health Solutions Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Lallemand Health Solutions Recent Developments and Future Plans
2.9 List Bio
2.9.1 List Bio Details
2.9.2 List Bio Major Business
2.9.3 List Bio Microbiome CDMO Product and Solutions
2.9.4 List Bio Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 List Bio Recent Developments and Future Plans
2.10 Rise BioServices
2.10.1 Rise BioServices Details
2.10.2 Rise BioServices Major Business
2.10.3 Rise BioServices Microbiome CDMO Product and Solutions
2.10.4 Rise BioServices Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Rise BioServices Recent Developments and Future Plans
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business
2.11.3 Lonza Microbiome CDMO Product and Solutions
2.11.4 Lonza Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Lonza Recent Developments and Future Plans
2.12 MaaT Pharma
2.12.1 MaaT Pharma Details
2.12.2 MaaT Pharma Major Business
2.12.3 MaaT Pharma Microbiome CDMO Product and Solutions
2.12.4 MaaT Pharma Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 MaaT Pharma Recent Developments and Future Plans
2.13 NIZO
2.13.1 NIZO Details
2.13.2 NIZO Major Business
2.13.3 NIZO Microbiome CDMO Product and Solutions
2.13.4 NIZO Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 NIZO Recent Developments and Future Plans
2.14 Quay Pharmaceuticals
2.14.1 Quay Pharmaceuticals Details
2.14.2 Quay Pharmaceuticals Major Business
2.14.3 Quay Pharmaceuticals Microbiome CDMO Product and Solutions
2.14.4 Quay Pharmaceuticals Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Quay Pharmaceuticals Recent Developments and Future Plans
2.15 Recipharm
2.15.1 Recipharm Details
2.15.2 Recipharm Major Business
2.15.3 Recipharm Microbiome CDMO Product and Solutions
2.15.4 Recipharm Microbiome CDMO Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Recipharm Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Microbiome CDMO Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Microbiome CDMO by Company Revenue
3.2.2 Top 3 Microbiome CDMO Players Market Share in 2025
3.2.3 Top 6 Microbiome CDMO Players Market Share in 2025
3.3 Microbiome CDMO Market: Overall Company Footprint Analysis
3.3.1 Microbiome CDMO Market: Region Footprint
3.3.2 Microbiome CDMO Market: Company Product Type Footprint
3.3.3 Microbiome CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Microbiome CDMO Consumption Value and Market Share by Type (2021-2026)
4.2 Global Microbiome CDMO Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Microbiome CDMO Consumption Value Market Share by Application (2021-2026)
5.2 Global Microbiome CDMO Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Microbiome CDMO Consumption Value by Type (2021-2032)
6.2 North America Microbiome CDMO Market Size by Application (2021-2032)
6.3 North America Microbiome CDMO Market Size by Country
6.3.1 North America Microbiome CDMO Consumption Value by Country (2021-2032)
6.3.2 United States Microbiome CDMO Market Size and Forecast (2021-2032)
6.3.3 Canada Microbiome CDMO Market Size and Forecast (2021-2032)
6.3.4 Mexico Microbiome CDMO Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Microbiome CDMO Consumption Value by Type (2021-2032)
7.2 Europe Microbiome CDMO Consumption Value by Application (2021-2032)
7.3 Europe Microbiome CDMO Market Size by Country
7.3.1 Europe Microbiome CDMO Consumption Value by Country (2021-2032)
7.3.2 Germany Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.3 France Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.5 Russia Microbiome CDMO Market Size and Forecast (2021-2032)
7.3.6 Italy Microbiome CDMO Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Microbiome CDMO Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Microbiome CDMO Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Microbiome CDMO Market Size by Region
8.3.1 Asia-Pacific Microbiome CDMO Consumption Value by Region (2021-2032)
8.3.2 China Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.3 Japan Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.4 South Korea Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.5 India Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Microbiome CDMO Market Size and Forecast (2021-2032)
8.3.7 Australia Microbiome CDMO Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Microbiome CDMO Consumption Value by Type (2021-2032)
9.2 South America Microbiome CDMO Consumption Value by Application (2021-2032)
9.3 South America Microbiome CDMO Market Size by Country
9.3.1 South America Microbiome CDMO Consumption Value by Country (2021-2032)
9.3.2 Brazil Microbiome CDMO Market Size and Forecast (2021-2032)
9.3.3 Argentina Microbiome CDMO Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Microbiome CDMO Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Microbiome CDMO Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Microbiome CDMO Market Size by Country
10.3.1 Middle East & Africa Microbiome CDMO Consumption Value by Country (2021-2032)
10.3.2 Turkey Microbiome CDMO Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Microbiome CDMO Market Size and Forecast (2021-2032)
10.3.4 UAE Microbiome CDMO Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Microbiome CDMO Market Drivers
11.2 Microbiome CDMO Market Restraints
11.3 Microbiome CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Microbiome CDMO Industry Chain
12.2 Microbiome CDMO Upstream Analysis
12.3 Microbiome CDMO Midstream Analysis
12.4 Microbiome CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Microbiome CDMO Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Microbiome CDMO Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Microbiome CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Microbiome CDMO Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Arranta Bio Company Information, Head Office, and Major Competitors
Table 6. Arranta Bio Major Business
Table 7. Arranta Bio Microbiome CDMO Product and Solutions
Table 8. Arranta Bio Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Arranta Bio Recent Developments and Future Plans
Table 10. Wacker Chemie AG Company Information, Head Office, and Major Competitors
Table 11. Wacker Chemie AG Major Business
Table 12. Wacker Chemie AG Microbiome CDMO Product and Solutions
Table 13. Wacker Chemie AG Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Wacker Chemie AG Recent Developments and Future Plans
Table 15. Bactera Company Information, Head Office, and Major Competitors
Table 16. Bactera Major Business
Table 17. Bactera Microbiome CDMO Product and Solutions
Table 18. Bactera Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. SGS Quay Pharma Company Information, Head Office, and Major Competitors
Table 20. SGS Quay Pharma Major Business
Table 21. SGS Quay Pharma Microbiome CDMO Product and Solutions
Table 22. SGS Quay Pharma Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. SGS Quay Pharma Recent Developments and Future Plans
Table 24. Biose Company Information, Head Office, and Major Competitors
Table 25. Biose Major Business
Table 26. Biose Microbiome CDMO Product and Solutions
Table 27. Biose Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Biose Recent Developments and Future Plans
Table 29. EnteroBiotix Company Information, Head Office, and Major Competitors
Table 30. EnteroBiotix Major Business
Table 31. EnteroBiotix Microbiome CDMO Product and Solutions
Table 32. EnteroBiotix Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. EnteroBiotix Recent Developments and Future Plans
Table 34. Genome And Company Company Information, Head Office, and Major Competitors
Table 35. Genome And Company Major Business
Table 36. Genome And Company Microbiome CDMO Product and Solutions
Table 37. Genome And Company Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Genome And Company Recent Developments and Future Plans
Table 39. Lallemand Health Solutions Company Information, Head Office, and Major Competitors
Table 40. Lallemand Health Solutions Major Business
Table 41. Lallemand Health Solutions Microbiome CDMO Product and Solutions
Table 42. Lallemand Health Solutions Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Lallemand Health Solutions Recent Developments and Future Plans
Table 44. List Bio Company Information, Head Office, and Major Competitors
Table 45. List Bio Major Business
Table 46. List Bio Microbiome CDMO Product and Solutions
Table 47. List Bio Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. List Bio Recent Developments and Future Plans
Table 49. Rise BioServices Company Information, Head Office, and Major Competitors
Table 50. Rise BioServices Major Business
Table 51. Rise BioServices Microbiome CDMO Product and Solutions
Table 52. Rise BioServices Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Rise BioServices Recent Developments and Future Plans
Table 54. Lonza Company Information, Head Office, and Major Competitors
Table 55. Lonza Major Business
Table 56. Lonza Microbiome CDMO Product and Solutions
Table 57. Lonza Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Lonza Recent Developments and Future Plans
Table 59. MaaT Pharma Company Information, Head Office, and Major Competitors
Table 60. MaaT Pharma Major Business
Table 61. MaaT Pharma Microbiome CDMO Product and Solutions
Table 62. MaaT Pharma Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. MaaT Pharma Recent Developments and Future Plans
Table 64. NIZO Company Information, Head Office, and Major Competitors
Table 65. NIZO Major Business
Table 66. NIZO Microbiome CDMO Product and Solutions
Table 67. NIZO Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. NIZO Recent Developments and Future Plans
Table 69. Quay Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 70. Quay Pharmaceuticals Major Business
Table 71. Quay Pharmaceuticals Microbiome CDMO Product and Solutions
Table 72. Quay Pharmaceuticals Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Quay Pharmaceuticals Recent Developments and Future Plans
Table 74. Recipharm Company Information, Head Office, and Major Competitors
Table 75. Recipharm Major Business
Table 76. Recipharm Microbiome CDMO Product and Solutions
Table 77. Recipharm Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Recipharm Recent Developments and Future Plans
Table 79. Global Microbiome CDMO Revenue (USD Million) by Players (2021-2026)
Table 80. Global Microbiome CDMO Revenue Share by Players (2021-2026)
Table 81. Breakdown of Microbiome CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Microbiome CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 83. Head Office of Key Microbiome CDMO Players
Table 84. Microbiome CDMO Market: Company Product Type Footprint
Table 85. Microbiome CDMO Market: Company Product Application Footprint
Table 86. Microbiome CDMO New Market Entrants and Barriers to Market Entry
Table 87. Microbiome CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Microbiome CDMO Consumption Value (USD Million) by Type (2021-2026)
Table 89. Global Microbiome CDMO Consumption Value Share by Type (2021-2026)
Table 90. Global Microbiome CDMO Consumption Value Forecast by Type (2027-2032)
Table 91. Global Microbiome CDMO Consumption Value by Application (2021-2026)
Table 92. Global Microbiome CDMO Consumption Value Forecast by Application (2027-2032)
Table 93. North America Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 94. North America Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 95. North America Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 96. North America Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 97. North America Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 98. North America Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 99. Europe Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 100. Europe Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 101. Europe Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 102. Europe Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 103. Europe Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 104. Europe Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Asia-Pacific Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 106. Asia-Pacific Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 107. Asia-Pacific Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Asia-Pacific Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Asia-Pacific Microbiome CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Microbiome CDMO Consumption Value by Region (2027-2032) & (USD Million)
Table 111. South America Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 112. South America Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 113. South America Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 114. South America Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 115. South America Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 116. South America Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Middle East & Africa Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Middle East & Africa Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Middle East & Africa Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Middle East & Africa Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Middle East & Africa Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 123. Global Key Players of Microbiome CDMO Upstream (Raw Materials)
Table 124. Global Microbiome CDMO Typical Customers
Table 1. Global Microbiome CDMO Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Microbiome CDMO Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Microbiome CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Microbiome CDMO Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Arranta Bio Company Information, Head Office, and Major Competitors
Table 6. Arranta Bio Major Business
Table 7. Arranta Bio Microbiome CDMO Product and Solutions
Table 8. Arranta Bio Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Arranta Bio Recent Developments and Future Plans
Table 10. Wacker Chemie AG Company Information, Head Office, and Major Competitors
Table 11. Wacker Chemie AG Major Business
Table 12. Wacker Chemie AG Microbiome CDMO Product and Solutions
Table 13. Wacker Chemie AG Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Wacker Chemie AG Recent Developments and Future Plans
Table 15. Bactera Company Information, Head Office, and Major Competitors
Table 16. Bactera Major Business
Table 17. Bactera Microbiome CDMO Product and Solutions
Table 18. Bactera Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. SGS Quay Pharma Company Information, Head Office, and Major Competitors
Table 20. SGS Quay Pharma Major Business
Table 21. SGS Quay Pharma Microbiome CDMO Product and Solutions
Table 22. SGS Quay Pharma Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. SGS Quay Pharma Recent Developments and Future Plans
Table 24. Biose Company Information, Head Office, and Major Competitors
Table 25. Biose Major Business
Table 26. Biose Microbiome CDMO Product and Solutions
Table 27. Biose Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Biose Recent Developments and Future Plans
Table 29. EnteroBiotix Company Information, Head Office, and Major Competitors
Table 30. EnteroBiotix Major Business
Table 31. EnteroBiotix Microbiome CDMO Product and Solutions
Table 32. EnteroBiotix Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. EnteroBiotix Recent Developments and Future Plans
Table 34. Genome And Company Company Information, Head Office, and Major Competitors
Table 35. Genome And Company Major Business
Table 36. Genome And Company Microbiome CDMO Product and Solutions
Table 37. Genome And Company Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Genome And Company Recent Developments and Future Plans
Table 39. Lallemand Health Solutions Company Information, Head Office, and Major Competitors
Table 40. Lallemand Health Solutions Major Business
Table 41. Lallemand Health Solutions Microbiome CDMO Product and Solutions
Table 42. Lallemand Health Solutions Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Lallemand Health Solutions Recent Developments and Future Plans
Table 44. List Bio Company Information, Head Office, and Major Competitors
Table 45. List Bio Major Business
Table 46. List Bio Microbiome CDMO Product and Solutions
Table 47. List Bio Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. List Bio Recent Developments and Future Plans
Table 49. Rise BioServices Company Information, Head Office, and Major Competitors
Table 50. Rise BioServices Major Business
Table 51. Rise BioServices Microbiome CDMO Product and Solutions
Table 52. Rise BioServices Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Rise BioServices Recent Developments and Future Plans
Table 54. Lonza Company Information, Head Office, and Major Competitors
Table 55. Lonza Major Business
Table 56. Lonza Microbiome CDMO Product and Solutions
Table 57. Lonza Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Lonza Recent Developments and Future Plans
Table 59. MaaT Pharma Company Information, Head Office, and Major Competitors
Table 60. MaaT Pharma Major Business
Table 61. MaaT Pharma Microbiome CDMO Product and Solutions
Table 62. MaaT Pharma Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. MaaT Pharma Recent Developments and Future Plans
Table 64. NIZO Company Information, Head Office, and Major Competitors
Table 65. NIZO Major Business
Table 66. NIZO Microbiome CDMO Product and Solutions
Table 67. NIZO Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. NIZO Recent Developments and Future Plans
Table 69. Quay Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 70. Quay Pharmaceuticals Major Business
Table 71. Quay Pharmaceuticals Microbiome CDMO Product and Solutions
Table 72. Quay Pharmaceuticals Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Quay Pharmaceuticals Recent Developments and Future Plans
Table 74. Recipharm Company Information, Head Office, and Major Competitors
Table 75. Recipharm Major Business
Table 76. Recipharm Microbiome CDMO Product and Solutions
Table 77. Recipharm Microbiome CDMO Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Recipharm Recent Developments and Future Plans
Table 79. Global Microbiome CDMO Revenue (USD Million) by Players (2021-2026)
Table 80. Global Microbiome CDMO Revenue Share by Players (2021-2026)
Table 81. Breakdown of Microbiome CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 82. Market Position of Players in Microbiome CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 83. Head Office of Key Microbiome CDMO Players
Table 84. Microbiome CDMO Market: Company Product Type Footprint
Table 85. Microbiome CDMO Market: Company Product Application Footprint
Table 86. Microbiome CDMO New Market Entrants and Barriers to Market Entry
Table 87. Microbiome CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 88. Global Microbiome CDMO Consumption Value (USD Million) by Type (2021-2026)
Table 89. Global Microbiome CDMO Consumption Value Share by Type (2021-2026)
Table 90. Global Microbiome CDMO Consumption Value Forecast by Type (2027-2032)
Table 91. Global Microbiome CDMO Consumption Value by Application (2021-2026)
Table 92. Global Microbiome CDMO Consumption Value Forecast by Application (2027-2032)
Table 93. North America Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 94. North America Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 95. North America Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 96. North America Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 97. North America Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 98. North America Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 99. Europe Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 100. Europe Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 101. Europe Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 102. Europe Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 103. Europe Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 104. Europe Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Asia-Pacific Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 106. Asia-Pacific Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 107. Asia-Pacific Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 108. Asia-Pacific Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 109. Asia-Pacific Microbiome CDMO Consumption Value by Region (2021-2026) & (USD Million)
Table 110. Asia-Pacific Microbiome CDMO Consumption Value by Region (2027-2032) & (USD Million)
Table 111. South America Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 112. South America Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 113. South America Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 114. South America Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 115. South America Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 116. South America Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 117. Middle East & Africa Microbiome CDMO Consumption Value by Type (2021-2026) & (USD Million)
Table 118. Middle East & Africa Microbiome CDMO Consumption Value by Type (2027-2032) & (USD Million)
Table 119. Middle East & Africa Microbiome CDMO Consumption Value by Application (2021-2026) & (USD Million)
Table 120. Middle East & Africa Microbiome CDMO Consumption Value by Application (2027-2032) & (USD Million)
Table 121. Middle East & Africa Microbiome CDMO Consumption Value by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Microbiome CDMO Consumption Value by Country (2027-2032) & (USD Million)
Table 123. Global Key Players of Microbiome CDMO Upstream (Raw Materials)
Table 124. Global Microbiome CDMO Typical Customers
LIST OF FIGURES
Figure 1. Microbiome CDMO Picture
Figure 2. Global Microbiome CDMO Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Microbiome CDMO Consumption Value Market Share by Type in 2025
Figure 4. Microbial CDMO
Figure 5. Antibiotic CDMO
Figure 6. Phage CDMO
Figure 7. Bacteriocins CDMO
Figure 8. Global Microbiome CDMO Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Microbiome CDMO Consumption Value Market Share by Application in 2025
Figure 10. Vaccine R&D Picture
Figure 11. Biopharmaceutical Picture
Figure 12. Cell Therapy Picture
Figure 13. Others Picture
Figure 14. Global Microbiome CDMO Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Microbiome CDMO Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Microbiome CDMO Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Microbiome CDMO Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Microbiome CDMO Consumption Value Market Share by Region in 2025
Figure 19. North America Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Microbiome CDMO Revenue Share by Players in 2025
Figure 26. Microbiome CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Microbiome CDMO by Player Revenue in 2025
Figure 28. Top 3 Microbiome CDMO Players Market Share in 2025
Figure 29. Top 6 Microbiome CDMO Players Market Share in 2025
Figure 30. Global Microbiome CDMO Consumption Value Share by Type (2021-2026)
Figure 31. Global Microbiome CDMO Market Share Forecast by Type (2027-2032)
Figure 32. Global Microbiome CDMO Consumption Value Share by Application (2021-2026)
Figure 33. Global Microbiome CDMO Market Share Forecast by Application (2027-2032)
Figure 34. North America Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 44. France Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Microbiome CDMO Consumption Value Market Share by Region (2021-2032)
Figure 51. China Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 54. India Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 68. Microbiome CDMO Market Drivers
Figure 69. Microbiome CDMO Market Restraints
Figure 70. Microbiome CDMO Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Microbiome CDMO Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Microbiome CDMO Picture
Figure 2. Global Microbiome CDMO Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Microbiome CDMO Consumption Value Market Share by Type in 2025
Figure 4. Microbial CDMO
Figure 5. Antibiotic CDMO
Figure 6. Phage CDMO
Figure 7. Bacteriocins CDMO
Figure 8. Global Microbiome CDMO Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 9. Microbiome CDMO Consumption Value Market Share by Application in 2025
Figure 10. Vaccine R&D Picture
Figure 11. Biopharmaceutical Picture
Figure 12. Cell Therapy Picture
Figure 13. Others Picture
Figure 14. Global Microbiome CDMO Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 15. Global Microbiome CDMO Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 16. Global Market Microbiome CDMO Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 17. Global Microbiome CDMO Consumption Value Market Share by Region (2021-2032)
Figure 18. Global Microbiome CDMO Consumption Value Market Share by Region in 2025
Figure 19. North America Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 20. Europe Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 21. Asia-Pacific Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 22. South America Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 23. Middle East & Africa Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Microbiome CDMO Revenue Share by Players in 2025
Figure 26. Microbiome CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 27. Market Share of Microbiome CDMO by Player Revenue in 2025
Figure 28. Top 3 Microbiome CDMO Players Market Share in 2025
Figure 29. Top 6 Microbiome CDMO Players Market Share in 2025
Figure 30. Global Microbiome CDMO Consumption Value Share by Type (2021-2026)
Figure 31. Global Microbiome CDMO Market Share Forecast by Type (2027-2032)
Figure 32. Global Microbiome CDMO Consumption Value Share by Application (2021-2026)
Figure 33. Global Microbiome CDMO Market Share Forecast by Application (2027-2032)
Figure 34. North America Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 35. North America Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 36. North America Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 41. Europe Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 42. Europe Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 43. Germany Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 44. France Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 45. United Kingdom Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 46. Russia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 47. Italy Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 48. Asia-Pacific Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 49. Asia-Pacific Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 50. Asia-Pacific Microbiome CDMO Consumption Value Market Share by Region (2021-2032)
Figure 51. China Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 52. Japan Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 53. South Korea Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 54. India Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 55. Southeast Asia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 56. Australia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 57. South America Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 58. South America Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 59. South America Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 60. Brazil Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 61. Argentina Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 62. Middle East & Africa Microbiome CDMO Consumption Value Market Share by Type (2021-2032)
Figure 63. Middle East & Africa Microbiome CDMO Consumption Value Market Share by Application (2021-2032)
Figure 64. Middle East & Africa Microbiome CDMO Consumption Value Market Share by Country (2021-2032)
Figure 65. Turkey Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 66. Saudi Arabia Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 67. UAE Microbiome CDMO Consumption Value (2021-2032) & (USD Million)
Figure 68. Microbiome CDMO Market Drivers
Figure 69. Microbiome CDMO Market Restraints
Figure 70. Microbiome CDMO Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Microbiome CDMO Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
